About DeepX Health
DeepX Health Ltd is part of a larger group of companies owned by DeepX Diagnostics Inc.
DeepX Diagnostic group (DXD) aims to become a world leader in cancer screening and analytics. We aim to do this by continual application of novel, ground-breaking technologies, medical algorithms (AI), and distribution models. Our mission is to save lives by detecting cancer in the early and curable stages. Our initial focus is on skin.
DermoSight is developed by companies in the DeepX Diagnostic group, and offered by DeepX Health Ltd.
In addition to offering the DermoSight TeleDermoscopy Solution the DXD company ScreenCancer deliver a teledermoscopy service in different European countries, having assessed more than 180,000 teledermoscopy cases.
Our DeepX UK Team
Contact our UK team to find out more on our product and services.
We are here to tailormake the best solution for your business!
Dr. Kurt Ayerst
Medical Director for DeepX in the UK.
Dermatology consultant. Chair of Dermatology Clinical Reference Group, a part of the NHS and former chair of the British Association of Dermatologists Skin Cancer committee.
Operational Manager for ScreenCancer UK. Joined the company in 2015 with a background in Dermatology both in the NHS and the private sector. Now looking after the UK team and operations for the UK and ROI.
Head of UK Business Development at DeepX Health.
Liaises with customers in NHS and private sector to ensure that patients get rapid access to cancer and skin screening, with NHS aim to save lives, reduce waiting list times and costs. Over 20 years in pharmaceutical industry working within primary and secondary care. Various therapeutic areas such as cancer, cardiology, dermatology, Allergy, Diabetes, Rheumatoid arthritis.
Started as a Business Admin apprentice in 2017, grew her knowledge and experience within the private side of the business ScreenCancer. Has extensive knowledge of the DermoSight Solution and is able to support partners of the solution in tech queries. Is now the Business Support Officer for ScreenCancer.
Send an Enquiry
Get in touch today!
Company no: 9557481 | c/o Kreston Reeves LLP Innovation House, Ramsgate Road, Sandwich, Kent CT13 9FF